Provider name: Elsevier Lot details Lot 1 Electronic Journals, Electronic Books, Databases, Aggregated Evidence Resource Summaries, Point
This guideline covers support for adults (aged 18 and over) who provide unpaid care for anyone aged 16 or over with health or social care needs. It aims to improve the lives of carers by helping health and social care practitioners identify people who are caring for someone and give them the right information and support. It covers carers’ assessments, practical, emotional and social support and training, and support for carers providing end of life care.
Evidence-based recommendations on reducing the risk of Creutzfeldt–Jakob disease (CJD) transmission from surgical instruments used for interventional procedures
Provider name: SAGE Lot details Lot 2 - Print journals, Electronic journals Provider helpdesk Customer account manager:
Evidence-based recommendations on osimertinib (Tagrisso) for untreated locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (NSCLC)
Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart
Everything NICE has said on preventing and controlling healthcare-associated infections in an interactive flowchart
Everything NICE has said on supporting adults carers in an interactive flowchart
Evidence-based recommendations on Virtual Touch Quantification for diagnosing and monitoring liver fibrosis in chronic Hepatitis B and C
Community pharmacy teams have the potential to play a greater role in health promotion and prevention says NICE, in a new draft quality standard.
Larotrectinib (also called Vitrakvi and made by Bayer), a new treatment for a range of cancers, can’t be recommended for use in the NHS because at its current price, it doesn’t have the potential to be cost-effective.
Everything NICE has said on antibiotic prescribing for self-limiting respiratory tract and ear infections in primary care in an interactive flowchart
Everything NICE has said on diagnosing and managing chronic hepatitis B in children, young people and adults in an interactive flowchart
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available on the Cancer Drugs Fund (CDF) following its approval by NICE in final guidance published today (15 January 2020).
Join our panel to give your expert advice on tools and resources developed to support NICE guidance.
Quick access to reliable information for health and social care professionals. Search HDAS, and other journals and databases.
NICE is unable to make a recommendation about the use in the NHS of atezolizumab (Tecentriq) with carboplatin and nab-paclitaxel for untreated advanced NSCLC
We're aiming to increase and extend the use of data in the development and evaluation of our guidance. Data sources could include: electronic health
Evidence-based recommendations on palbociclib (Ibrance) with fulvestrant for hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer
Evidence-based recommendations on olaparib (Lynparza) for relapsed platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer in adults with a
Doctors can check on their patients remotely using Reveal LINQ monitor
Everything NICE has said on diagnosing and treating advanced breast cancer in an interactive flowchart
Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart
We work with an independent Indicator Advisory Committee (IAC) to develop indicators suitable for potential inclusion in the Quality and Outcomes...
What is a retro?
This quality standard covers increasing the uptake of flu vaccination among people who are eligible. It describes high-quality care in priority areas for improvement.
This quality standard covers assessing, diagnosing and managing rheumatoid arthritis in over 16s. It describes high-quality care in priority areas for improvement.
This guideline covers indoor air quality in residential buildings. It aims to raise awareness of the importance of good air quality in people's homes and how to achieve this.
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
Evidence-based recommendations on lusutrombopag (Mulpleo) for severe thrombocytopenia in adults with chronic liver disease needing a planned invasive procedure
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Everything NICE has said on influenza in an interactive flowchart
Everything NICE has said on liver conditions in an interactive flowchart
Everything NICE has said on diagnosing and managing non-alcoholic fatty liver disease and advanced liver fibrosis in an interactive flowchart
Everything NICE has said on liver and bile duct cancers in an interactive flowchart
Everything NICE has said on assessing and managing suspected or confirmed cirrhosis in people over 16 in an interactive flowchart
Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart
Submit your shared learning entry by 4 March 2020 for a chance to be one of our 20 finalists at this year’s NICE Conference
Feedback from the GP reference panel survey
Our panel aims to gather the collective wisdom of GPs on the ground who might not otherwise be heard.
Everything NICE has said on improving air quality to prevent ill health in an interactive flowchart